Breathing exercises to improve lung function
Impact of Breathing Exercises on Lung Function in Chronic Airway Diseases
NA · Mansoura University Hospital · NCT06472167
This study tests if breathing exercises can help people with chronic lung diseases like COPD and asthma breathe better and feel more active.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mansoura University Hospital (other) |
| Locations | 1 site (Al Mansurah) |
| Trial ID | NCT06472167 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a pulmonary rehabilitation program that focuses on breathing exercises for individuals with chronic airway diseases like COPD and asthma. The program aims to enhance functional capacity, reduce dyspnea, and improve pulmonary function through techniques such as diaphragmatic breathing and pursed lip breathing. Participants will be assessed using the six-minute walking distance test and the Medical Research Council dyspnea scale, among other measures. The goal is to help patients use their lungs more effectively and improve their overall quality of life.
Who should consider this trial
Good fit: Ideal candidates include clinically stable COPD and asthmatic patients who are ex-smokers and have not participated in any prior exercise-training programs.
Not a fit: Patients under 18, current smokers, or those with multiple comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance lung function and quality of life for patients with chronic airway diseases.
How similar studies have performed: Other studies have shown positive outcomes with similar non-pharmacological approaches to managing chronic airway diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patients fulfilled the criteria for COPD: the presence of a post bronchodilator FEV1 \< 80% predicated together with an FEV1/FVC \<0.70confirm the presence of airflow limitation that is not fully reversible. * COPD patients ranging from mild to severe according to GOLD \[stages I-IV\]. * Asthmatic patients receive medical treatment for at least 6 months; and clinically stable (i.e., no exacerbation or changes in medication for ≥30 days). * None of the individuals had been engaged in any exercise-training program before participating in the study. * Optimized medical therapy according to GOLD \& Global Initiative for Asthma (GINA) * Clinically stable COPD and asthmatic patients (not suffering from a recent respiratory tract infection). * All patients are Ex-smoker Exclusion Criteria: * Age \<18 years. * Pregnancy * Current Smokers * Patients that are incapable of exercising; unable to understand any questionnaire * Multiple co- morbidity (e.g., cardiovascular diseases, active cancer) * Neuromuscular disease as Myasthenia gravis, kypho-scoliosis * Diaphragmatic Paralysis (paralyzed diaphragm exhibiting abnormal paradoxical movement, i.e., moving in a cranial direction during inspiration).
Where this trial is running
Al Mansurah
- Mohamed AbdElmoniem — Al Mansurah, Egypt (RECRUITING)
Study contacts
- Principal investigator: Mohamed AbdElmoniem — Lecturer of chest medicine faculty of medicine Mansoura university
- Study coordinator: Mohamed AbdElmoniem
- Email: dr.m1993@mans.edu.eg
- Phone: 01014008473
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breathing Exercises, Breathing exercises, lung function, Chronic airway diseases